Search Results - "Vis, Marije M"

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI by Wykrzykowska, Joanna J, Kraak, Robin P, Hofma, Sjoerd H, van der Schaaf, Rene J, Arkenbout, E. Karin, IJsselmuiden, Alexander J, Elias, Joëlle, van Dongen, Ivo M, Tijssen, Ruben Y.G, Koch, Karel T, Baan, Jan, Vis, M. Marije, de Winter, Robbert J, Piek, Jan J, Tijssen, Jan G.P, Henriques, Jose P.S

“…In a randomized trial, 1845 patients undergoing PCI were assigned to receive either everolimus-eluting bioresorbable vascular scaffolds or everolimus-eluting…”
Get full text

Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction by Ouweneel, Dagmar M., Eriksen, Erlend, Sjauw, Krischan D., van Dongen, Ivo M., Hirsch, Alexander, Packer, Erik J.S., Vis, M. Marije, Wykrzykowska, Joanna J., Koch, Karel T., Baan, Jan, de Winter, Robbert J., Piek, Jan J., Lagrand, Wim K., de Mol, Bas A.J.M., Tijssen, Jan G.P., Henriques, José P.S.

“…Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) remains high. Short-term mechanical…”
Get full text

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial by Dewilde, Willem JM, Dr, Oirbans, Tom, MSc, Verheugt, Freek WA, Prof, Kelder, Johannes C, MD, De Smet, Bart JGL, MD, Herrman, Jean-Paul, MD, Adriaenssens, Tom, MD, Vrolix, Mathias, MD, Heestermans, Antonius ACM, MD, Vis, Marije M, MD, Tijsen, Jan GP, Prof, van 't Hof, Arnoud W, MD, ten Berg, Jurriën M, MD

“…Summary Background If percutaneous coronary intervention (PCI) is required in patients taking oral anticoagulants, antiplatelet therapy with aspirin and…”
Get full text

The Prognostic Value of Bleeding Academic Research Consortium (BARC)-Defined Bleeding Complications in ST-Segment Elevation Myocardial Infarction by Kikkert, Wouter J., MD, van Geloven, Nan, PhD, van der Laan, Mariet H, Vis, Marije M., MD, PhD, Baan, Jan, MD, PhD, Koch, Karel T., MD, PhD, Peters, Ron J., MD, PhD, de Winter, Robbert J., MD, PhD, Piek, Jan J., MD, PhD, Tijssen, Jan G.P., PhD, Henriques, José P.S., MD, PhD

“…Objectives The aim of the present analysis was to compare 1-year mortality prediction of Bleeding Academic Research Consortium (BARC)-defined bleeding…”
Get full text

Myocardial fibrosis predicts adverse outcome after MitraClip implantation by Velu, Juliëtte F., Hirsch, Alexander, Boekholdt, S. M., Koch, Karel T., Marije Vis, M., Nils Planken, R., Piek, Jan J., Baan, Jan, Bouma, Berto J.

“…Background High‐risk patients with mitral regurgitation (MR) may be treated by a percutaneous mitral valve repair with the MitraClip, but identification of…”
Get full text

DEtection of ProxImal Coronary stenosis in the work-up for Transcatheter aortic valve implantation using CTA (from the DEPICT CTA collaboration) by van den Boogert, Thomas P. W., Claessen, Bimmer E. P. M., Opolski, Maksymilian P., Kim, Won-Keun, Hamdan, Ashraf, Andreini, Daniele, Pugliese, Francesca, Möllmann, Helge, Delewi, Ronak, Baan, Jan, Vis, M. Marije, van Randen, Adrienne, van Schuppen, Joost, Stoker, Jaap, Henriques, José P., Planken, R. Nils

“…Objectives Computed tomography angiography (CTA) is performed routinely in the work-up for transcatheter aortic valve implantation (TAVI), and could…”
Get full text

Impact of Aortic Valve Stenosis on Coronary Hemodynamics and the Instantaneous Effect of Transcatheter Aortic Valve Implantation by Wiegerinck, Esther M.A, van de Hoef, Tim P, Rolandi, M Cristina, Yong, ZeYie, van Kesteren, Floortje, Koch, Karel T, Vis, Marije M, de Mol, Bas A.J.M, Piek, Jan J, Baan, Jan

“…BACKGROUND—Aortic valve stenosis (AS) induces compensatory alterations in left ventricular hemodynamics, leading to physiological and pathological alterations…”
Get full text

Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock by Hemradj, Veemal V, Karami, Mina, Sjauw, Krischan D, Engström, Annemarie E, Ouweneel, Dagmar M, de Brabander, Justin, Vis, Marije M, Wykrzykowska, Joanna J, Beijk, Marcel A, Koch, Karel T, Baan, Jan, de Winter, Robbert J, Piek, Jan J, Driessen, Antoine H. G, Lagrand, Wim K, Vlaar, Alexander P. J, Ottervanger, Jan Paul, Henriques, José P. S

“…Background In selected patients with an acute myocardial infarction (AMI) complicated by Cardiogenic shock (CS), mechanical circulatory support with Impella…”
Get full text

Effect of Multivessel Coronary Disease With or Without Concurrent Chronic Total Occlusion on One-Year Mortality in Patients Treated With Primary Percutaneous Coronary Intervention for Cardiogenic Shock by van der Schaaf, René J., MD, Claessen, Bimmer E., MD, Vis, M. Marije, MD, Hoebers, Loes P., MD, Koch, Karel T., MD, PhD, Baan, Jan, MD, PhD, Meuwissen, Martijn, MD, PhD, Engstrom, Annemarie E., MD, Kikkert, Wouter J., MD, Tijssen, Jan G.P., PhD, de Winter, Robbert J., MD, PhD, Piek, Jan J., MD, PhD, Henriques, José P.S., MD, PhD

“…Despite early revascularization, mortality remains high in patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock…”
Get full text

Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis by Baan, Jan, MD, PhD, Yong, Ze Yie, MD, Koch, Karel T., MD, PhD, Henriques, José P.S., MD, PhD, Bouma, Berto J., MD, PhD, Vis, Marije M., MD, Cocchieri, Riccardo, MD, Piek, Jan J., MD, PhD, de Mol, Bas A.J.M., MD, PhD

“…Background Cardiac conduction disorders and requirement for permanent pacemaker implantation (PPI) are not uncommon after surgical aortic valve replacement and…”
Get full text

Evaluation of the Effect of a Concurrent Chronic Total Occlusion on Long-Term Mortality and Left Ventricular Function in Patients After Primary Percutaneous Coronary Intervention by Claessen, Bimmer E.P.M., MD, van der Schaaf, René J., MD, Verouden, Niels J., MD, Stegenga, Nienke K., MSc, Engstrom, Annemarie E., MD, Sjauw, Krischan D., MD, Kikkert, Wouter J., MD, Vis, Marije M., MD, Baan, Jan, MD, PhD, Koch, Karel T., MD, PhD, de Winter, Robbert J., MD, PhD, Tijssen, Jan G.P., PhD, Piek, Jan J., MD, PhD, Henriques, José P.S., MD, PhD

“…Objectives The aim of this study was to evaluate the effect of a concurrent chronic total occlusion (CTO) in patients with ST-segment elevation myocardial…”
Get full text

Amsterdam Investigator–initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design by Woudstra, Pier, MD, Grundeken, Maik J., MD, Kraak, Robin P., MD, Hassell, Mariëlla E.C.J., MD, Arkenbout, E. Karin, PhD, MD, Baan, Jan, PhD, MD, Vis, Marije M., PhD, MD, Koch, Karel T., MD, PhD, Tijssen, Jan G.P., PhD, Piek, Jan J., MD, PhD, de Winter, Robbert J., MD, PhD, Henriques, José P.S., MD, PhD, Wykrzykowska, Joanna J., MD, PhD

“…Background The Absorb everolimus-eluting bioresorbable vascular scaffold (AbsorbBVS) is a completely resorbable device engineered to overcome the limitations…”
Get full text

CT determined psoas muscle area predicts mortality in women undergoing transcatheter aortic valve implantation by van Mourik, Martijn S., Janmaat, Yvonne C., van Kesteren, Floortje, Vendrik, Jeroen, Planken, R. Nils, Henstra, Marieke J., Velu, Juliëtte F., Vlastra, Wieneke, Zwinderman, Aeilko H., Koch, Karel T., de Winter, Robbert J., Wykrzykowska, Joanna J., Piek, Jan J., Henriques, José P. S., Lanting, Vincent R., Baan, Jan, Latour, Corine, Lindeboom, Robert, Vis, M. Marije

“…Objectives The aim of this study was to assess the predictive value of PMA measurement for mortality. Background Current surgical risk stratification have…”
Get full text

Impact of Potentially Malignant Incidental Findings by Computed Tomographic Angiography on Long-Term Survival After Transcatheter Aortic Valve Implantation by van Kesteren, Floortje, Wiegerinck, Esther M.A., van Mourik, Martijn S., Vis, M. Marije, Koch, Karel T., Piek, Jan J., Stoker, Jaap, Tijssen, Jan G., Baan, Jan, Planken, R. Nils

“…Computed tomography angiography (CTA) in workup for transcatheter aortic valve implantation (TAVI) frequently reveals potentially malignant incidental…”
Get full text

Multiple Biomarkers at Admission Significantly Improve the Prediction of Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction by Damman, Peter, MD, Beijk, Marcel A.M., MD, Kuijt, Wichert J., MD, Verouden, Niels J.W., MD, van Geloven, Nan, MSc, Henriques, José P.S., MD, PhD, Baan, Jan, MD, PhD, Vis, Marije M., MD, Meuwissen, Martijn, MD, PhD, van Straalen, Jan P, Fischer, Johan, PhD, Koch, Karel T., MD, PhD, Piek, Jan J., MD, PhD, Tijssen, Jan G.P., PhD, de Winter, Robbert J., MD, PhD

“…Objectives We investigated whether multiple biomarkers improve prognostication in ST-segment elevation myocardial infarction (STEMI) patients undergoing…”
Get full text

Value of a comprehensive geriatric assessment for predicting one-year outcomes in patients undergoing transcatheter aortic valve implantation: results from the CGA-TAVI multicentre registry by van Mourik, Martijn S, van der Velde, Nathalie, Mannarino, Giulio, Thibodeau, Marie-Pierre, Masson, Jean-Bernard, Santoro, Gennaro, Baan, Jan, Jansen, Sofie, Kurucova, Jana, Thoenes, Martin, Deutsch, Cornelia, Schoenenberger, Andreas W, Ungar, Andrea, Bramlage, Peter, Vis, M Marije

“…In a three-month report from the CGA-TAVI registry, we found the Multidimensional Prognostic Index (MPI) and Short Physical Performance Battery (SPPB) to be of…”
Get full text

A Systematic Review and Meta-Analysis on Primary Percutaneous Coronary Intervention of an Unprotected Left Main Coronary Artery Culprit Lesion in the Setting of Acute Myocardial Infarction by Vis, Marije M., MD, Beijk, Marcel A., MD, PhD, Grundeken, Maik J., MD, Baan, Jan, MD, PhD, Koch, Karel T., MD, PhD, Wykrzykowska, Joanna J., MD, PhD, Arkenbout, E. Karin, MD, PhD, Tijssen, Jan G.P., PhD, de Winter, Robbert J., MD, PhD, Piek, Jan J., MD, PhD, Henriques, José P.S., MD, PhD

“…Objectives This study sought to evaluate 30-day all-cause mortality of patients treated with primary percutaneous coronary intervention (PCI) presenting with…”
Get full text

Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics by Remmelink, Maurice, Sjauw, Krischan D., Henriques, José P.S., de Winter, Robbert J., Koch, Karel T., van der Schaaf, René J., Vis, Marije M., Tijssen, Jan G.P., Piek, Jan J., Baan Jr, Jan

“…Objectives: We studied the effects of LV unloading by the Impella on coronary hemodynamics by simultaneously measuring intracoronary pressure and flow and the…”
Get full text

Predictive Value of Plasma Glucose Level on Admission for Short and Long Term Mortality in Patients With ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention by Hoebers, Loes P., MD, Damman, Peter, MD, Claessen, Bimmer E., MD, Vis, Marije M., MD, Baan, Jan, MD, van Straalen, Jan P, Fischer, Johan, PhD, Koch, Karel T., MD, PhD, Tijssen, Jan G.P., PhD, de Winter, Robbert J., MD, PhD, Piek, Jan J., MD, PhD, Henriques, Jose P.S., MD, PhD

“…Published reports describe a strong association between plasma glucose levels on admission and mortality in patients who undergo primary percutaneous coronary…”
Get full text

Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction by Kikkert, Wouter J., MD, Hoebers, Loes P., MD, Damman, Peter, MD, PhD, Lieve, Krystien V.V, Claessen, Bimmer E.P.M., MD, PhD, Vis, Marije M., MD, PhD, Baan, Jan, MD, PhD, Koch, Karel T., MD, PhD, de Winter, Robbert J., MD, PhD, Piek, Jan J., MD, PhD, Tijssen, Jan G.P., PhD, Henriques, Jose P.S., MD, PhD

“…The determinants and prognostic value of recurrent myocardial infarction (MI) in a contemporary cohort of ST-segment elevation MI patients treated with primary…”
Get full text